Target
Cyclin-dependent kinase 7
Ligand
BDBM395709
Substrate
n/a
Meas. Tech.
Kinase Activity Assay
IC50
550±n/a nM
Citation
 Ciblat, SKabro, ALeblanc, MLeger, SMarineau, JJMiller, TRoy, SSchmidt, DSiddiqui, MASprott, KWinter, DKRipka, ALi, DZhang, G Inhibitors of cyclin-dependent kinase 7 (CDK7) US Patent  US10865206 Publication Date 12/15/2020 
Target
Name:
Cyclin-dependent kinase 7
Synonyms:
39 kDa protein kinase | CAK | CAK1 | CDK-activating kinase | CDK-activating kinase 1 (CAK) | CDK7 | CDK7_HUMAN | CDKN7 | Cell division protein kinase 7 | Cyclin-Dependent Kinase 7 (CDK7) | Cyclin-dependent kinase 7 (CDK7/cyclin H) | MO15 | P39 Mo15 | STK1 | TFIIH basal transcription factor complex kinase subunit
Type:
Enzyme Subunit
Mol. Mass.:
39047.01
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
346
Sequence:
MALDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEALEQGGLPKKLIF
  
Inhibitor
Name:
BDBM395709
Synonyms:
4-amino-N-(5-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)bicyclo[3.1.1]heptan-1-yl)benzamide | US10308648, Compound 104 | US10865206, Compound 104
Type:
Small organic molecule
Emp. Form.:
C26H25ClN6O
Mol. Mass.:
472.969
SMILES:
Nc1ccc(cc1)C(=O)NC12CC(C1)(CCC2)Nc1ncc(Cl)c(n1)-c1c[nH]c2ccccc12 |(8.13,1.76,;6.79,2.53,;5.41,1.79,;4.08,2.56,;4.08,4.1,;5.41,4.87,;6.74,4.1,;2.74,4.87,;2.74,6.41,;1.41,4.1,;.08,4.87,;-1.26,4.1,;-2.59,4.87,;-1.26,5.64,;-2.59,6.41,;-1.26,7.18,;.08,6.41,;-3.93,4.1,;-5.26,4.87,;-5.26,6.41,;-6.59,7.18,;-7.93,6.41,;-9.26,7.18,;-7.93,4.87,;-6.59,4.1,;-9.26,4.1,;-9.26,2.56,;-10.72,2.08,;-11.63,3.33,;-13.16,3.49,;-13.79,4.9,;-12.88,6.14,;-11.35,5.98,;-10.72,4.57,)|
Structure:
Search PDB for entries with ligand similarity: